scispace - formally typeset
Open AccessJournal ArticleDOI

Predicting drug-disease associations by using similarity constrained matrix factorization

Reads0
Chats0
TLDR
A user-friendly web server is developed by using known associations collected from the CTD database, available at http://www.bioinfotech.cn/SCMFDD, which makes use of known drug-disease associations, drug features and disease semantic information.
Abstract
Drug-disease associations provide important information for the drug discovery. Wet experiments that identify drug-disease associations are time-consuming and expensive. However, many drug-disease associations are still unobserved or unknown. The development of computational methods for predicting unobserved drug-disease associations is an important and urgent task. In this paper, we proposed a similarity constrained matrix factorization method for the drug-disease association prediction (SCMFDD), which makes use of known drug-disease associations, drug features and disease semantic information. SCMFDD projects the drug-disease association relationship into two low-rank spaces, which uncover latent features for drugs and diseases, and then introduces drug feature-based similarities and disease semantic similarity as constraints for drugs and diseases in low-rank spaces. Different from the classic matrix factorization technique, SCMFDD takes the biological context of the problem into account. In computational experiments, the proposed method can produce high-accuracy performances on benchmark datasets, and outperform existing state-of-the-art prediction methods when evaluated by five-fold cross validation and independent testing. We developed a user-friendly web server by using known associations collected from the CTD database, available at http://www.bioinfotech.cn/SCMFDD/ . The case studies show that the server can find out novel associations, which are not included in the CTD database.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Graph embedding on biomedical networks: methods, applications and evaluations.

TL;DR: Xiang et al. as mentioned in this paper evaluated graph embedding methods on biomedical networks and found that the learned embeddings can be treated as complementary representations for the biological features, and provided general guidelines for properly selecting graph embeding methods and setting their hyper-parameters for different biomedical tasks.
Journal ArticleDOI

Predicting drug-disease associations through layer attention graph convolutional network.

TL;DR: This study reveals that embeddings from different convolution layers can reflect the proximities of different orders, and combining theembeddings by the attention mechanism can improve the prediction performances.
Journal ArticleDOI

SFPEL-LPI: Sequence-based feature projection ensemble learning for predicting LncRNA-protein interactions

TL;DR: The sequence-based feature projection ensemble learning method, “SFPEL-LPI”, is proposed, which accurately predicts lncRNA-protein associations and outperforms other state-of-the-art methods.
Journal ArticleDOI

Constructing knowledge graphs and their biomedical applications.

TL;DR: This review discusses how knowledge graphs are constructed and applied with a particular focus on how machine learning approaches are changing these processes, and notes potential avenues for future work with knowledge graphs that appear particularly promising.
Journal ArticleDOI

Developing a Multi-Dose Computational Model for Drug-Induced Hepatotoxicity Prediction Based on Toxicogenomics Data

TL;DR: Results show that the drug-induced hepatotoxicity can be predicted with high accuracy and efficiency using the proposed predictive model and a new feature selection method, named MEMO, to deal with the high-dimensional toxicogenomics data.
References
More filters
Journal ArticleDOI

KEGG for representation and analysis of molecular networks involving diseases and drugs

TL;DR: The new disease/drug information resource named KEGG MEDICUS can be used as a reference knowledge base for computational analysis of molecular networks, especially, by integrating large-scale experimental datasets.
Journal ArticleDOI

DrugBank 4.0: shedding new light on drug metabolism

TL;DR: The latest update of DrugBank, DrugBank 4.0, has been further expanded to contain data on drug metabolism, absorption, distribution, metabolism, excretion and toxicity (ADMET) and other kinds of quantitative structure activity relationships (QSAR) information.
Journal ArticleDOI

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

TL;DR: The increasing risk of agranulocytosis with age and the reduced incidence after the first six months of treatment provide additional guidelines for the prescription and monitoring of clozapine treatment in the future.
Journal ArticleDOI

Estimating The Cost Of New Drug Development: Is It Really $802 Million?

TL;DR: This paper replicates the drug development cost estimates of Joseph DiMasi and colleagues, using their published cost estimates along with information on success rates and durations from a publicly available data set, to estimate the cost per new drug between 1989 and 2002.
Journal ArticleDOI

PREDICT: a method for inferring novel drug indications with application to personalized medicine.

TL;DR: A novel method for the large‐scale prediction of drug indications (PREDICT) that can handle both approved drugs and novel molecules and lays the computational foundation for future personalized drug treatments, where gene expression signatures from individual patients would replace the disease‐specific signatures.
Related Papers (5)